Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The record on rosiglitazone and the risk of myocardial infarction.

× No keyword cloud information.

35 in total

1. Rosiglitazone: a European regulatory perspective.

Authors: E Blind; K Dunder; P A de Graeff; E Abadie
Journal: Diabetologia Date: 2010-12-14 Impact factor: 10.122

2. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors: D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal: Diabetologia Date: 2008-01 Impact factor: 10.122

3. Drug-related risks.

Authors: Ulrich Klotz
Journal: Eur J Clin Pharmacol Date: 2007-11 Impact factor: 2.953

Review 4. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook.

Authors: Laura Cerny; John S Torday; Virender K Rehan
Journal: Lung Date: 2008-01-30 Impact factor: 2.584

5. Rosiglitazone and implications for pharmacovigilance.

Authors: Dhruv Kazi
Journal: BMJ Date: 2007-06-16

6. Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline.

Authors: Lei Yu; Xin Jin; Yang Yang; Ningren Cui; Chun Jiang
Journal: Br J Pharmacol Date: 2011-12 Impact factor: 8.739

Review 7. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.

Authors: Helen Vosper
Journal: Br J Pharmacol Date: 2009-07-20 Impact factor: 8.739

8. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study.

Authors: David N Juurlink; Tara Gomes; Lorraine L Lipscombe; Peter C Austin; Janet E Hux; Muhammad M Mamdani
Journal: BMJ Date: 2009-08-18

9. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Authors: Ioanna Tzoulaki; Mariam Molokhia; Vasa Curcin; Mark P Little; Christopher J Millett; Anthea Ng; Robert I Hughes; Kamlesh Khunti; Martin R Wilkins; Azeem Majeed; Paul Elliott
Journal: BMJ Date: 2009-12-03

10. Changes in glitazone use among office-based physicians in the U.S., 2003-2009.

Authors: Andrew Cohen; Atonu Rabbani; Nilay Shah; G Caleb Alexander
Journal: Diabetes Care Date: 2010-01-26 Impact factor: 19.112